{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T09:38:18Z","timestamp":1785317898429,"version":"3.55.0"},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2015,2,25]],"date-time":"2015-02-25T00:00:00Z","timestamp":1424822400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Bioinformatics"],"published-print":{"date-parts":[[2015,12]]},"DOI":"10.1186\/s12859-015-0478-3","type":"journal-article","created":{"date-parts":[[2015,2,24]],"date-time":"2015-02-24T00:35:29Z","timestamp":1424738129000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":90,"title":["Removing batch effects from purified plasma cell gene expression microarrays with modified ComBat"],"prefix":"10.1186","volume":"16","author":[{"given":"Caleb K","family":"Stein","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pingping","family":"Qu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joshua","family":"Epstein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amy","family":"Buros","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adam","family":"Rosenthal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Crowley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gareth","family":"Morgan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bart","family":"Barlogie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2015,2,25]]},"reference":[{"issue":"12","key":"478_CR1","doi-asserted-by":"publisher","first-page":"2210","DOI":"10.1038\/leu.2009.174","volume":"23","author":"R Fonseca","year":"2009","unstructured":"Fonseca R, Bergsagel PL, Drach J, Shaughnessy J, Gutierrez N, Stewart AK, et al. International myeloma working group molecular classification of multiple myeloma: spotlight review. Leukemia. 2009; 23(12):2210\u201321.","journal-title":"Leukemia."},{"issue":"5","key":"478_CR2","doi-asserted-by":"publisher","first-page":"1745","DOI":"10.1182\/blood.V99.5.1745","volume":"99","author":"F Zhan","year":"2002","unstructured":"Zhan F, Hardin J, Kordsmeier B, Bumm K, Zheng M, Tian E, et al. Global gene expression profiling of multiple myeloma, monoclonal gammopathy of undetermined significance, and normal bone marrow plasma cells. Blood. 2002; 99(5):1745\u201357.","journal-title":"Blood."},{"issue":"3","key":"478_CR3","doi-asserted-by":"publisher","first-page":"1128","DOI":"10.1182\/blood-2002-06-1737","volume":"101","author":"F Zhan","year":"2003","unstructured":"Zhan F, Tian E, Bumm K, Smith R, Barlogie B, Shaughnessy J. Gene expression profiling of human plasma cell differentiation and classification of multiple myeloma based on similarities to distinct stages of late-stage b-cell development. Blood. 2003; 101(3):1128\u201340.","journal-title":"Blood."},{"key":"478_CR4","doi-asserted-by":"publisher","first-page":"2410","DOI":"10.1038\/leu.2014.232","volume":"28","author":"C Heuck","year":"2014","unstructured":"Heuck C, Qu P, van Rhee F, Waheed S, Usmani S, Epstein J, et al. Five gene probes carry most of the discriminatory power of the 70-gene risk model in multiple myeloma. Leukemia. 2014; 28:2410\u201313.","journal-title":"Leukemia."},{"issue":"6","key":"478_CR5","doi-asserted-by":"publisher","first-page":"2276","DOI":"10.1182\/blood-2006-07-038430","volume":"109","author":"J Shaughnessy","year":"2007","unstructured":"Shaughnessy J, Zhan F, Burington BE, Huang Y, Colla S, Hanamura I, et al. A validated gene expression model of high-risk multiple myeloma is defined by deregulated expression of genes mapping to chromosome 1. Blood. 2007; 109(6):2276\u201384.","journal-title":"Blood."},{"issue":"13","key":"478_CR6","doi-asserted-by":"publisher","first-page":"3512","DOI":"10.1182\/blood-2010-12-328252","volume":"118","author":"J Shaughnessy","year":"2011","unstructured":"Shaughnessy J, Qu P, Usmani S, Heuck CJ, Zhang Q, Zhou Y, et al. Pharmacogenetics of bortezomib test-dosing identifies hyperexpression of proteasome genes, especially psmd4, as novel high-risk feature in myeloma treated with total therapy 3. Blood. 2011; 118(13):3512\u201324.","journal-title":"Blood."},{"key":"478_CR7","doi-asserted-by":"publisher","first-page":"2406","DOI":"10.1038\/leu.2012.127","volume":"26","author":"R Kuiper","year":"2012","unstructured":"Kuiper R, Byoyl A, de Knegt Y, van Vliet MH, van Beers EH, van der Holt B, et al. A gene expression signature for high-risk multiple myeloma. Leukemia. 2012; 26:2406\u201313.","journal-title":"Leukemia."},{"issue":"6","key":"478_CR8","doi-asserted-by":"publisher","first-page":"1856","DOI":"10.1158\/1078-0432.CCR-09-2831","volume":"16","author":"NJ Dickens","year":"2010","unstructured":"Dickens NJ, Walker BA, Leonoe PE, Johnson DC, Brito JL, Zeisig A, et al. Homozygous deletion mapping in myeloma samples identifies genes and an expression signature relevant to pathogenesis and outcome. Clin Cancer Res. 2010; 16(6):1856\u201364.","journal-title":"Clin Cancer Res."},{"issue":"8","key":"478_CR9","doi-asserted-by":"publisher","first-page":"3177","DOI":"10.1182\/blood-2006-09-044974","volume":"109","author":"G Mulligan","year":"2007","unstructured":"Mulligan G, Mitsiades C, Bryant B, Zhan F, Chng WJ, Roels S, et al. Gene expression profiling and correlation withoutcome in clinical trials of the proteasome inhibitor bortezomib. Blood. 2007; 109(8):3177\u201388.","journal-title":"Blood."},{"issue":"29","key":"478_CR10","doi-asserted-by":"publisher","first-page":"4798","DOI":"10.1200\/JCO.2007.13.8545","volume":"26","author":"O Decaux","year":"2008","unstructured":"Decaux O, Lode L, Magrangeas F, Charbonnel C, Gouraud W, Jezequel P, et al. Prediction of survival in multiple myeloma based on gene expression profiles reveals cell cycle and chromosomal instability signatures in high-risk patients and hyperdiploid signatures in low-risk patients: a study of the intergroupe francophone du myelome. J Clin Oncol. 2008; 26(29):4798\u2013805.","journal-title":"J Clin Oncol."},{"issue":"6","key":"478_CR11","doi-asserted-by":"publisher","first-page":"530","DOI":"10.1111\/j.1365-2141.2007.06586.x","volume":"137","author":"JD Shaughnessy","year":"2009","unstructured":"Shaughnessy JD, Haessler J, van Rhee F, Anaissie E, Pineda-Roman M, Cottler-Fox M, et al. Testing standard and genetic parameters in 220 patients with multiple myeloma with complete data sets: superiority of molecular genetics. Br J Haematology. 2009; 137(6):530\u20136.","journal-title":"Br J Haematology."},{"issue":"8","key":"478_CR12","first-page":"489","volume":"11","author":"N Biran","year":"2013","unstructured":"Biran N, Jagannath S, Chari A. Risk stratification in multiple myeloma, part 1: Characterization of high-risk disease. Clical Adv Hematol Oncol. 2013; 11(8):489\u2013503.","journal-title":"Clical Adv Hematol Oncol"},{"issue":"1","key":"478_CR13","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1182\/blood-2013-07-515239","volume":"123","author":"MV Dhodapkar","year":"2014","unstructured":"Dhodapkar MV, Sexton R, Waheed S, Usmani S, Papanikalaou X, Nair B, et al. Clinical, genomic, and imaging predictors of myeloma prgoression from anymptomatic monoclonal gammopathies (swog s0120). Blood. 2014; 123(1):78\u201385.","journal-title":"Blood."},{"key":"478_CR14","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1038\/tpj.2010.57","volume":"10","author":"J Luo","year":"2010","unstructured":"Luo J, Schumacher M, Scherer A, Sanoudou D, Megherbi D, Davison T, et al. A comparison of batch effect removal methods for enhancement of prediction performance using maqc-ii microarry gene expression data. Pharmacogenomics J. 2010; 10:278\u201391.","journal-title":"Pharmacogenomics J."},{"key":"478_CR15","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1186\/1755-8794-5-23","volume":"5","author":"P Kupfer","year":"2012","unstructured":"Kupfer P, Guthke R, Pohlers D, Huber R, Koczan D, Kinne RW. Batch correction of microarray data substantially improves the identification of genes differentially expressed in rheumatoid arthritis and osteoarthritis. BMC Med Genomics. 2012; 5:23.","journal-title":"BMC Med Genomics."},{"key":"478_CR16","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1038\/nrg2825","volume":"11","author":"JT Leek","year":"2010","unstructured":"Leek JT, Scharpf RB, Bravo HC, Simcha D, Langmead B, Johnson WE, et al. Tackling the widespread and critical impact of batch effects in high-throughput data. Nat Rev Genet. 2010; 11:733\u20139.","journal-title":"Nat Rev Genet."},{"issue":"21","key":"478_CR17","doi-asserted-by":"crossref","first-page":"1865","DOI":"10.1182\/blood.V122.21.1865.1865","volume":"122","author":"Q Zhang","year":"2013","unstructured":"Zhang Q, Heuck C, Qu P, Usmani S, Williams R, Zhou Y, et al. Gene expression profiling-based risk stratification scores in multiple myeloma can be highly sensitive towards sample preparation. Blood. 2013; 122(21):1865.","journal-title":"Blood."},{"issue":"1","key":"478_CR18","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1182\/blood-2011-06-357038","volume":"119","author":"G Morgan","year":"2012","unstructured":"Morgan G, Gregory W, Davies F, Bell S, Szubert A, Brown J, et al. The role of maintenance thalidomide therapy in multiple myeloma: Mrc myeloma ix results and meta-analysis. Blood. 2012; 119(1):7\u201315.","journal-title":"Blood."},{"issue":"1","key":"478_CR19","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1093\/biostatistics\/kxj037","volume":"8","author":"WE Johnson","year":"2007","unstructured":"Johnson WE, Li C, Rabinovic A. Adjusting batch effects in microarray expression data using empirical bayes methods. Biostatistics. 2007; 8(1):118\u201327.","journal-title":"Biostatistics."},{"issue":"2","key":"478_CR20","doi-asserted-by":"publisher","first-page":"17238","DOI":"10.1371\/journal.pone.0017238","volume":"6","author":"C Chen","year":"2011","unstructured":"Chen C, Grennan K, Badner J, Zhang D, Gershon E, Jin L, et al. Removing batch effects in analysis of expression microarray data: An evaluation of six batch adjustment methods. PLoS ONE. 2011; 6(2):17238.","journal-title":"PLoS ONE."},{"issue":"3","key":"478_CR21","doi-asserted-by":"publisher","first-page":"18202","DOI":"10.1371\/journal.pone.0018202","volume":"6","author":"PA Konstantinopoulos","year":"2011","unstructured":"Konstantinopoulos PA, Cannistra SA, Fountzilas H, Culhane A, Pillay K, Rueda B, et al. Integrated analysis of multiple microarray datasets identifies a reproducible survival predictor in ovarian cancer. PLoS ONE. 2011; 6(3):18202.","journal-title":"PLoS ONE."},{"issue":"16","key":"478_CR22","doi-asserted-by":"publisher","first-page":"9440","DOI":"10.1073\/pnas.1530509100","volume":"100","author":"JD Storey","year":"2003","unstructured":"Storey JD, Tibshirani R. Statistical significance for genomewide studies. Proc Natl Acad Sci USA. 2003; 100(16):9440\u20135.","journal-title":"Proc Natl Acad Sci USA."}],"container-title":["BMC Bioinformatics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12859-015-0478-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12859-015-0478-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12859-015-0478-3","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12859-015-0478-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,8,30]],"date-time":"2020-08-30T07:05:02Z","timestamp":1598771102000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcbioinformatics.biomedcentral.com\/articles\/10.1186\/s12859-015-0478-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,2,25]]},"references-count":22,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2015,12]]}},"alternative-id":["478"],"URL":"https:\/\/doi.org\/10.1186\/s12859-015-0478-3","relation":{},"ISSN":["1471-2105"],"issn-type":[{"value":"1471-2105","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,2,25]]},"assertion":[{"value":"8 January 2015","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 January 2015","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 February 2015","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"63"}}